|
EP3725769A1
|
|
Process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives
|
|
EP3725768A1
|
|
Process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives
|
|
NZ619577A
|
|
Fluorinated arylalkylaminocarboxamide derivatives
|
|
WO2011134763A1
|
|
Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers
|
|
WO2009109334A1
|
|
(s)-(+)-2-[4-fluorbenzyloxy)benzylamino]propanamide for use in the treatment of mixed or combined pain
|
|
NZ586182A
|
|
Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
|
|
NZ585806A
|
|
Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree
|
|
RS56780B1
|
|
Substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators
|
|
AU2007263328A1
|
|
Process for the production of 2- [4 - ( 3- and 2-fluorobenzyloxy) benzylamino] propan amides
|
|
US2008319057A1
|
|
2-phenylethylamino derivatives as calcium and/or sodium channel modulators
|
|
EP1870097A1
|
|
Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
|
|
NZ560666A
|
|
Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
|
|
NZ553970A
|
|
Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators
|
|
NZ547392A
|
|
N-acyl-N'-benzyl-alkylendiamino derivatives
|
|
AU2004266494A1
|
|
Alpha-aminoamide derivatives useful as anti-inflammatory agents
|
|
EP1588704A1
|
|
Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
|
|
KR20110070929A
|
|
Methods for treatment of parkinson's disease
|
|
EP1557166A1
|
|
Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
|
|
EP1541547A1
|
|
Hydroxylamine derivatives
|
|
EP1535908A1
|
|
N-acyl-N'-benzyl-alkylendiamino drivatives
|
